These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30272043)

  • 21. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
    Riemann A; Güttler A; Haupt V; Wichmann H; Reime S; Bache M; Vordermark D; Thews O
    Oncol Res; 2018 Mar; 26(2):191-200. PubMed ID: 28631600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated carbonic anhydrases and their inhibition.
    Pastorekova S; Zatovicova M; Pastorek J
    Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
    Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.
    Angeli A; Carta F; Nocentini A; Winum JY; Zalubovskis R; Akdemir A; Onnis V; Eldehna WM; Capasso C; Simone G; Monti SM; Carradori S; Donald WA; Dedhar S; Supuran CT
    Metabolites; 2020 Oct; 10(10):. PubMed ID: 33066524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
    Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
    Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
    Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.
    Supuran CT
    J Exp Pharmacol; 2020; 12():603-617. PubMed ID: 33364855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
    Pastorek J; Pastorekova S
    Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors.
    Eldehna WM; El Hassab MA; Abdelshafi NA; Eissa RA; Diab NH; Mohamed EH; Oraby MA; Al-Rashood ST; Eissa RG; Elsayed ZM; Nocentini A; Supuran CT; Elsabahy M; Eissa NG
    Int J Pharm; 2023 Jan; 631():122537. PubMed ID: 36572260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V
    Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
    Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
    J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
    De Luca L; Mancuso F; Ferro S; Buemi MR; Angeli A; Del Prete S; Capasso C; Supuran CT; Gitto R
    Eur J Med Chem; 2018 Jan; 143():276-282. PubMed ID: 29197732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
    Maresca A; Supuran CT
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4511-4. PubMed ID: 20580555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of carbonic anhydrase IX as a novel anticancer mechanism.
    Supuran CT
    World J Clin Oncol; 2012 Jul; 3(7):98-103. PubMed ID: 22787577
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.